822 public posts
Want to take advantage of all our features? Just log in!
or
FDA grants fast track designation to CAR T-cell therapy for SLE
[/i]
[i][/i]
CB-010 also is being tested as a potential treatment for refractory B-cell non-Hodgkin lymphoma, a type of blood cancer, in a Phase 1 clinical trial dubbed ANTLER (NCT04637763).
Review article summarises management strategies for those with CLL harbouring complex karyotype
On 6 January 2025, the journal [i]BJ Haem[/i] published a review article titled [i]Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype[/i] written by a team from Padua, Italy. The article summary explains its aims:
[i]"Chronic lymphocytic leukaemia